Key result
Ventricular assist device implantation in patients with prosthetic heart valves resulted in a 30-day mortality of 50% (3 of 6 patients).
Why the study?
Does ventricular assist device implantation provide reasonable clinical outcomes in patients with prosthetic heart valves?
Observational (n=6)
No
Does ventricular assist device implantation provide reasonable clinical outcomes in patients with prosthetic heart valves?
Ventricular assist device implantation in patients with prosthetic heart valves is a feasible option that can successfully bridge patients to transplantation or recovery, despite high perioperative risks.
No takes yet. Share an insight, caveat, or question.
Raises caution for VAD use in prosthetic valve patients; leaves open feasibility as bridge therapy pending larger studies.
Mokashi et al. (2010) conducted an observational in Prosthetic heart valves requiring ventricular assist device support (n=6). Ventricular assist device (VAD) implantation was evaluated on 30-day mortality. Ventricular assist device implantation in patients with prosthetic heart valves resulted in a 30-day mortality of 50% (3 of 6 patients).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: